396 related articles for article (PubMed ID: 7578072)
1. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
[TBL] [Abstract][Full Text] [Related]
2. The three-dimensional solution structure of human stefin A.
Martin JR; Craven CJ; Jerala R; Kroon-Zitko L; Zerovnik E; Turk V; Waltho JP
J Mol Biol; 1995 Feb; 246(2):331-43. PubMed ID: 7869384
[TBL] [Abstract][Full Text] [Related]
3. Wild-type and met-65-->Leu variants of human cystatin A are functionally and structurally identical.
Craven CJ; Baxter NJ; Murray EH; Hill NJ; Martin JR; Ylinenjärvi K; Björk I; Waltho JP; Murray IA
Biochemistry; 2000 Dec; 39(51):15783-90. PubMed ID: 11123903
[TBL] [Abstract][Full Text] [Related]
4. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
5. Human cystatin A is inactivated by engineered truncation. The NH2-terminal region of the cysteine proteinase inhibitor is essential for expression of its inhibitory activity.
Shibuya K; Kaji H; Itoh T; Ohyama Y; Tsujikami A; Tate S; Takeda A; Kumagai I; Hirao I; Miura K
Biochemistry; 1995 Sep; 34(38):12185-92. PubMed ID: 7547959
[TBL] [Abstract][Full Text] [Related]
6. Structural characterisation of human stefin A in solution and implications for binding to cysteine proteinases.
Martin JR; Jerala R; Kroon-Zitko L; Zerovnik E; Turk V; Waltho JP
Eur J Biochem; 1994 Nov; 225(3):1181-94. PubMed ID: 7957209
[TBL] [Abstract][Full Text] [Related]
7. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
Pol E; Björk I
Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
[TBL] [Abstract][Full Text] [Related]
8. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
9. Conformational variability of chicken cystatin. Comparison of structures determined by X-ray diffraction and NMR spectroscopy.
Engh RA; Dieckmann T; Bode W; Auerswald EA; Turk V; Huber R; Oschkinat H
J Mol Biol; 1993 Dec; 234(4):1060-9. PubMed ID: 8263913
[TBL] [Abstract][Full Text] [Related]
10. The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.
Powers R; Garrett DS; March CJ; Frieden EA; Gronenborn AM; Clore GM
Biochemistry; 1993 Jul; 32(26):6744-62. PubMed ID: 8329398
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional solution structure of the N-terminal domain of DNA polymerase beta and mapping of the ssDNA interaction interface.
Liu D; Prasad R; Wilson SH; DeRose EF; Mullen GP
Biochemistry; 1996 May; 35(20):6188-200. PubMed ID: 8639559
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for different inhibitory specificities of human cystatins C and D.
Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M
Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728
[TBL] [Abstract][Full Text] [Related]
13. Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy.
Kraulis PJ; Domaille PJ; Campbell-Burk SL; Van Aken T; Laue ED
Biochemistry; 1994 Mar; 33(12):3515-31. PubMed ID: 8142349
[TBL] [Abstract][Full Text] [Related]
14. Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN.
Hiltke TR; Lee TC; Bobek LA
J Dent Res; 1999 Aug; 78(8):1401-9. PubMed ID: 10439027
[TBL] [Abstract][Full Text] [Related]
15. The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.
Estrada S; Nycander M; Hill NJ; Craven CJ; Waltho JP; Björk I
Biochemistry; 1998 May; 37(20):7551-60. PubMed ID: 9585570
[TBL] [Abstract][Full Text] [Related]
16. The solution structure of bovine ferricytochrome b5 determined using heteronuclear NMR methods.
Muskett FW; Kelly GP; Whitford D
J Mol Biol; 1996 Apr; 258(1):172-89. PubMed ID: 8613986
[TBL] [Abstract][Full Text] [Related]
17. Major differences in stability and dimerization properties of two chimeric mutants of human stefins.
Kenig M; Jerala R; Kroon-Zitko L; Turk V; Zerovnik E
Proteins; 2001 Mar; 42(4):512-22. PubMed ID: 11170205
[TBL] [Abstract][Full Text] [Related]
18. High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy.
Moy FJ; Seddon AP; Böhlen P; Powers R
Biochemistry; 1996 Oct; 35(42):13552-61. PubMed ID: 8885834
[TBL] [Abstract][Full Text] [Related]
19. The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction.
Stubbs MT; Laber B; Bode W; Huber R; Jerala R; Lenarcic B; Turk V
EMBO J; 1990 Jun; 9(6):1939-47. PubMed ID: 2347312
[TBL] [Abstract][Full Text] [Related]
20. NMR structural studies of human cystatin C dimers and monomers.
Ekiel I; Abrahamson M; Fulton DB; Lindahl P; Storer AC; Levadoux W; Lafrance M; Labelle S; Pomerleau Y; Groleau D; LeSauteur L; Gehring K
J Mol Biol; 1997 Aug; 271(2):266-77. PubMed ID: 9268658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
